Wolff–Parkinson syndrome in pregnancy: risks and management dilemmas—a review of literature,10.1007/s11296-008-0075-3,European Clinics in Obstetrics a

Wolff–Parkinson syndrome in pregnancy: risks and management dilemmas—a review of literature


	BibTex \| RIS \| RefWorks Download

, ,

Though uncommon, Wolff–Parkinson–White syndrome (WPW) can cause life threatening cardiac rhythm disorders in pregnancy. We examine a case report of a 20-year-old primigravida with WPW referred by her GP at 16 weeks of gestation. After consultation with the tertiary care cardiac treatment centre, she was prescribed flecainide (40 mg twice daily), resulting in a settling of the palpitations and chest pain. In pregnant WPW syndrome patients with tachyarrhythmia, therapeutic strategies should be based on interdisciplinary co-operation (obstetrics, cardiology, and neonatology). With an appropriate management strategy, most pregnant women will have a normal and uneventful pregnancy.

Journal: European Clinics in Obstetrics and Gynaecology , vol. 3, no. 3, pp. 123-126, 2008

DOI: 10.1007/s11296-008-0075-3

Cumulative Annual

View Publication

( www.springerlink.com )

Keywords (7)

Wolff–Parkinson syndrome in pregnancy: risks and management dilemmas—a review of literature,10.1007/s11296-008-0075-3,European Clinics in Obstetrics a

References (13)

Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome (Citations: 7)

WPW syndrome during pregnancy: Increased incidence of supraventricular arrhythmias (Citations: 45)

Persistent Supraventricular Tachycardia Following Infusion with Ritodrine Hydrochloride (Citations: 7)

Supraventricular tachycardia in pregnancy (Citations: 6)

Adenosine therapy for supraventricular tachycardia during pregnancy (Citations: 23)


	The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.